Home > Healthcare > Medical Devices > Therapeutic Devices > Cardiac Ablation Market

Cardiac Ablation Market Size

  • Report ID: GMI3702
  • Published Date: Dec 2022
  • Report Format: PDF

Cardiac Ablation Market Size

Cardiac Ablation Market size was valued at over USD 3.5 billion in 2022 and is projected to observe over 13.5% CAGR between 2023 to 2032.

 

High caffeine intake, adoption of a sedentary lifestyle, overconsumption of alcohol and tobacco, substance abuse, and smoking habits are factors that are likely to contribute to increasing occurrences of cardiac ailments. As per WHO, over 1.9 million people across the world die due to tobacco-related cardiac disorders each year. Other estimates from the American Heart Association (AHA) suggest that cardiovascular ailments account for nearly 800,000 U.S. deaths annually, of which 20% of cases are due to cigarette smoking.

 

High cardiac ablation-related risks may constrain industry development

In the short run, the risks related to cardiac ablation procedures may hinder cardiac ablation market progress. Some of the cardiac ablation surgery-related risks include infections, damage to blood vessels, and pulmonary stenosis. Moreover, a rare complication associated with catheter-based ablation is the development of an atrial-esophageal fistula and esophageal injury is likely to affect patient preference for the procedure. As per the Journal of AHA, 1 in 18 patients undergoing atrial fibrillation ablation encountered a procedural complication within 30 days of hospital discharge with bleeding and pericardial effusion.
 

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market for cardiac ablation held a valuation of over USD 3.5 billion in 2020 and is anticipated to grow at over 13.5% CAGR between 2023 and 2032.

Europe cardiac ablation industry is poised to reach a valuation of over USD 4 billion by 2032, driven by factors like rising adoption of innovative technologies and increasing healthcare spending.

Electrical ablators segment is poised to record at 14% CAGR from 2023 to 2032, driven by continuous development in surgical technologies and increasing R&D efforts.

Leading players in cardiac ablation market include Abbott Laboratories, Angiodynamics, Atricure, Biosense Webster (Johnson & Johnson), Medtronic, and Boston Scientific Corporation, among others.

Cardiac Ablation Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 10
  • Tables & Figures: 262
  • Countries covered: 19
  • Pages: 175
 Download Free Sample